Giovanni Fucà
31PUBLICATIONS
63CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (31)
Sort by Publication Date:
|Apr 15, 2025
Navigating the Landscape of Resistance Mechanisms in Antibody-Drug Conjugates for Cancer Treatment.Gloria Lalli, Ilaria Sabatucci, Mariachiara Paderno
|Jul 29, 2024
The clinical landscape of antibody-drug conjugates in endometrial cancer.Giovanni Fucà, Ilaria Sabatucci, Mariachiara Paderno
|Aug 24, 2023
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial.Francesca Ligorio, Riccardo Lobefaro, Giovanni Fucà
|Apr 17, 2023
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.Emma Zattarin, Daniele Presti, Luigi Mariani
|Mar 19, 2022
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.Giovanni Fucà, Alessandra Raimondi, Michele Prisciandaro
|Feb 03, 2022
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers.Giovanni Fucà, Romain Cohen, Sara Lonardi
Pageof 6
Frequent Collaborators
7 joint publications
Filippo Pietrantonio
4 joint publications
Claudio Vernieri
3 joint publications
Federica Morano
3 joint publications
Sara Lonardi
2 joint publications
Rita Leporati
2 joint publications
Salvatore Corallo
2 joint publications
Annunziata Gloghini
2 joint publications
Caterina Sposetti
2 joint publications
Francesca Ligorio
1 joint publications
Serenella Pupa
